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Abstract
Background: Mycobacterium tuberculosis is characterised by limited genomic diversity, which makes the application
of whole genome sequencing particularly attractive for clinical and epidemiological investigation. However, in order
to confidently infer transmission events, an accurate knowledge of the rate of change in the genome over relevant
timescales is required.
Methods: We attempted to estimate a molecular clock by sequencing 199 isolates from epidemiologically linked
tuberculosis cases, collected in the Netherlands spanning almost 16 years.
Results: Multiple analyses support an average mutation rate of ~0.3 SNPs per genome per year. However, all
analyses revealed a very high degree of variation around this mean, making the confirmation of links proposed by
epidemiology, and inference of novel links, difficult. Despite this, in some cases, the phylogenetic context of other
strains provided evidence supporting the confident exclusion of previously inferred epidemiological links.
Conclusions: This in-depth analysis of the molecular clock revealed that it is slow and variable over short time
scales, which limits its usefulness in transmission studies. However, the superior resolution of whole genome
sequencing can provide the phylogenetic context to allow the confident exclusion of possible transmission events
previously inferred via traditional DNA fingerprinting techniques and epidemiological cluster investigation. Despite
the slow generation of variation even at the whole genome level we conclude that the investigation of
tuberculosis transmission will benefit greatly from routine whole genome sequencing.
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Background
The global burden of tuberculosis remains enormous,
resulting in 1.4 million deaths, and 8.7 million new cases in
2011 [1]. Understanding transmission dynamics, and the
host and pathogen factors that can affect the spread of tu-
berculosis, is vital for understanding epidemiology and for
effective outbreak management. In order to achieve this,
the accurate identification of transmission events through
epidemiological and molecular techniques is essential.
In the last two decades several DNA fingerprinting
methods for Mycobacterium tuberculosis were developed
that reveal different types of DNA polymorphisms in the
genome [2]. The first typing method developed used
IS6110 restriction fragment length polymorphism (RFLP)
analysis, but variable number of tandem repeat (VNTR)
typing is currently recognised as the gold standard [3,4].
In the Netherlands, a country with a low incidence of tu-
berculosis (6.5 per 100,000 people), epidemiological links
between patients are considered “confirmed” if two con-
ditions are met: 1) two M. tuberculosis isolates have an
identical RFLP or VNTR profile and 2) interviews suggest
that both patients could have been in contact with each
other. Genomic changes that are independent of sites
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monitored by RFLP/VNTR typing, however, are unac-
counted for. For some questions concerning the disease,
the application of RFLP and VNTR typing is limited. For
example Niemann et al. found that two M. tuberculosis
isolates had the same RFLP type but differed by 130 SNPs
when whole genome sequencing was used [5]. Likewise,
isolates with identical DNA fingerprints may not always
be epidemiologically linked. For example Gardy et al.
found that VNTR typing data suggested a tuberculosis
outbreak in Canada was clonal, whereas whole genome se-
quencing data revealed that there were in fact two concur-
rent outbreaks [6]. Moreover, RFLP and VNTR typing may
suffer from a slow genetic turn over that reduces their use-
fulness when epidemiological clusters grow over extended
time periods. In such case the distinction between spread
from primary, secondary, tertiary, etc., sources in the clus-
ter becomes impossible. Whole genome sequencing allows
investigation into genomic evolution and transmission at
the highest resolution. This level of information can help
refine conclusions drawn from traditional fingerprinting
methods. The application of sequencing to a large out-
break in Harlingen, the Netherlands, provided a higher re-
solution picture than could be inferred from typing alone,
and reduced the possible number of infection routes for
all patients, which agreed with epidemiological inves-
tigations [7].
Due to its slow growth and limited genomic diversity,
routine application of clinical whole genome sequencing is
particularly attractive for M. tuberculosis. This will make
the determination of both antibiotic resistance and trans-
mission events more rapid [8]. However, in order to confi-
dently conclude transmission, knowledge of the mutation
rate is required. Whole genome sequencing has demon-
strated that M. tuberculosis is characterized by low gen-
omic diversity [9] suggesting that its mutation rate is low.
However, very few studies have attempted to make an ac-
curate measurement of mutation rate. Ford et al. showed
using whole genome sequencing, that the mutation rate of
M. tuberculosis during active infection of macaques is ap-
proximately 0.39 (0.16-0.80 95% CI) single nucleotide poly-
morphisms per genome per year [10]. However, this was
based on only 15 isolates collected from four infections.
More recently, an estimate of 0.5 SNPs/genome/year has
been made on the basis of within and between patient
sampling of 93 patients from a larger study in the UK [11].
In order to better understand the mutation rate in M.
tuberculosis during transmission, the genomes of 199
isolates were sequenced. These included isolates from
185 patients with known epidemiological links, and an-
other 14 patient isolates from the same RFLP clusters
but with no evident epidemiological link. Here we assess
the usefulness of the molecular clock and the phylogen-
etic resolution provided by whole genome sequencing
to both refute and affirm epidemiological inference.
Methods
Contact tracing
Contact tracing was carried out as part of routine hand-
ling by the Municipal Health Service in Amsterdam, and
performed following the stone-in-the-pond principle
[12]. Contacts were examined in groups, located in con-
centric circles around the source case, until the observed
prevalence of tuberculosis infection corresponds with
the expected prevalence. Patients whose isolates had an
identical IS6110 RFLP fingerprint were extensively in-
terviewed. The data of these interviews were combined
with the contact tracing results, and anonymised for this
analysis; therefore data protection permission and ethical
approval were not required.
Genotyping methods
IS6110 restriction fragment length polymorphism (RFLP)
typing was performed for all isolates in the study.
Spoligotyping, 24-locus variable number of tandem repeats
(VNTR) typing were performed on some isolates by the
standardized methods detailed elsewhere [3,13,14].
Strain selection
Strains of 42 IS6110 RFLP clusters that contained isolates
of epidemiologically linked TB patients were selected for
whole genome sequencing. Patient data was anonymised
and un-identifiable, therefore ethical approval and in-
formed consent were not required. As control strains, the
source case isolate and the isolate of the fifth patient in a
transmission chain of the Harlingen cluster that were part
of an earlier WGS study [9] were sequenced. Using 454-
sequencing and comparative analysis, these two genome
sequences had been determined to differ by four SNPs [9].
Also, four multidrug resistant (MDR) isolates of patients
diagnosed in Estonia, of which two were linked by trans-
mission, were sequenced. These isolates are representative
of cluster EU0051 [15] (de Beer et al., manuscript in prep-
aration) that is one of the largest European MDR –clusters
to date. DNA was isolated according to the previously
published protocol [16].
Library construction and sequencing
Libraries were constructed in 18 pools of isolates with
each isolate uniquely tagged. Each pool was subjected to
paired-end sequencing on a single lane of the Illumina
Genome Analyzer GAIIx platform. Thirty-three of the
isolates were sequenced with a read length of 76 bases
and the remaining 166 with a read length of 108 bases.
All raw sequence data used in this work have been
deposited in the European Nucleotide Archive under
Study Accession Number: ERP000111.
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Data analysis
Reads were mapped to a corrected version of the H37Rv
reference [17] using the program SMALT [18]; and a com-
bination of samtools and bcftools [19] were used to call
bases as part of an in-house pipeline. Appropriate filters
were used to reduce the number of false positive SNP calls
to a level estimated to be less than 1 SNP per genome.
These included at least 75% of high quality mapped reads
on each strand agreeing with the call, a base quality score
of at least 50 and a mapping quality score of at least 30.
Reads which did not map uniquely were discarded, which
means repetitive regions are avoided. Mapping and SNP
calling were also carried out independently at the Center
of Molecular and Biomolecular Informatics (CMBI),
Radboud University, using RoVar (Robust Variant detec-
tion in genome sequences using Next Generation Data
from various platforms). RoVar is available upon request
from the authors (https://trac.nbic.nl/rovar/, V.C.L. de
Jager, B.A.M. Renckens, R.J. Siezen, and S.A.F.T. van
Hijum, unpublished). The mapping results were compared
using the epidemiological linked pairs as a test set. Most
SNPs were found to agree except those found in regions
flanking insertions. This problem was avoided by only
calling deletions in the final mapping. As short insertions
and deletions are difficult to call in general, only SNPs
were considered for all subsequent analysis. The repetitive
and GC rich PE/PPE gene family are known to be prob-
lematic for analysis with short read data. Most variants in
these regions were filtered out due to the quality controls
mentioned above. However, to completely account for the
possibility of unreliable SNPs called in these regions, the
mutation rate analyses were repeated with these regions
removed (Additional file 1). It should be noted that this
made no impact on the conclusions drawn.
Phylogenetic analysis
A maximum likelihood tree was constructed based on
variable positions using RAxML [20]. Homoplasic SNPs
(indicated by identical SNPs that occurred on independ-
ent branches of the tree) were inspected manually to dis-
count any that were likely to be the result of incorrect
mapping. Path-O-Gen was used to plot root to tip dis-
tance against time [21]. This program uses linear regres-
sion to root trees with date information at the position
that is most compatible with the assumption of the pres-
ence of a molecular clock.
Results
Whole genome phylogeny and microevolution between
epidemiologically linked pairs
For this study, 199 isolates were selected at the Municiple
Health Service in Amsterdam representing 42 RFLP
clusters of various sizes (Additional file 2). This included
97 pairs of isolates for which an epidemiological link was
established via contact tracing within the RFLP clusters.
The selection included strains of a variety of spoligotype-
defined lineages and drug resistance profiles. DNA from
each of these isolates was sequenced using the Illumina
platform, generating an average coverage of 95.6% of the
genome to a depth of approximately 100 fold. Mapping of
this data from the 199 isolates to the H37Rv reference
genome revealed 11,879 positions that had a SNP in at
least one of the isolates. A maximum-likelihood phylogeny
was constructed based on positions of the genome found
to contain a SNP, revealing four of the globally dominant
lineages (Figure 1). All RFLP defined clusters were in
agreement with clusters identified on the whole genome
SNP tree.
The genetic distance was calculated between each of
the 97 pairs by comparing the SNPs called in each iso-
late. A SNP difference was only counted where there
was high confidence in the base call in both isolates.
The linked pairs had a mean SNP difference of 3.42
(range of 0–149) and 37 of the pairs had no detectable
SNP difference (Figure 2) demonstrating high genomic
stability.
Convergent evolution of drug resistance
Eight of the epidemiologically linked pairs had different
drug susceptibility phenotypes for streptomycin and isonia-
zid. In five of the pairs, a resistant phenotype was found in
the primary case isolate, and in three of the pairs it was
found in the secondary (see Additional file 3). However no
SNPs in genes known or suspected to confer drug resist-
ance were identified to differ between the pairs. In addition
minority variants and InDels (insertions and deletions)
were also investigated, but no additional variants could be
detected. Although this could indicate an undetected
mechanism or variant which determines resistance, it may
also be due to inaccuracies in the phenotypic resistance
tests.
In total, 16 non-synonymous SNPs were found to be
homoplasic (Additional file 4). Five of these found in
genes rpoB [23], gyrA [24], rrs [25], katG [26] and embB
[27] have previously been associated with drug resistance.
Two of the other homoplasic SNPs occurred in genes
thought to be involved in pathogenicity: ino1 [28] and
opcA [29]. One possibility is that convergent evolution
could be a result of recombination. It has recently been
suggested that recombination is frequent and widespread
within the M. tuberculosis species [30], which is counter
to a widespread belief that it is strictly clonal. We analysed
our data using a recombination detection program [31]
and found no evidence of recombination in our dataset.
Instead, it is more likely that homoplasy has occurred
in these genes due to a high selective pressure for traits
such as antibiotic resistance. This suggests that the other
11 homoplasic SNPs with no ascribed function deserve
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Figure 1 Maximum likelihood phylogeny of 199M.tuberculosis strains from 11,879 single nucleotide polymorphisms. Lineages are
indicated as described by [22].
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Figure 2 Pairwise genetic distances between M. tuberculosis isolates from patients linked by contact tracing. The genetic distances
consist of the number of identified single nucleotide polymorphisms that differed between the genomes of two linked isolates.
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further investigation, as they may possibly represent previ-
ously un-described pathogenicity or antibiotic-resistance
genes conferring selective advantages or potential com-
pensatory mutations [32].
Deriving a molecular clock
In order to make a judgment about whether direct trans-
mission has taken place using whole genome sequencing
data, knowledge of the mutation rate is required. Here we
have attempted to estimate this using the epidemiologically
linked pairs. Estimates were calculated using SNPs ac-
cumulated in the secondary case in each of the linked
pairs. SNPs found only in the primary case isolate were
excluded as these are likely to represent either variation in
the source host population that is not present in the trans-
mitted population, or SNPs generated via laboratory pas-
sage. SNPs conferring drug resistance were excluded
(n = 7), as these are likely to be subject to strong selection.
In addition three pairs were excluded based on the phylo-
genetic evidence discussed below. The mutation rate was
estimated per pair, with sources of error such as diagnostic
delay and false positive and false negative SNP calls taken
into account (See Additional file 5). The average estimates
were wide ranging (0.4-17) with a mean of 5.37 SNPs per
genome per year (see Additional file 5). No association be-
tween higher estimates and patient factors including sex,
country of birth, treatment and drug susceptibility of the
isolates was found (Fishers exact test P values 0.11 - 1).
When the number of SNPs accumulated was plotted
against time elapsed for each patient pair a poor correl-
ation was observed (Figure 3a). However, when drug resist-
ant and sensitive pairs were plotted separately an improved
correlation for sensitive pairs was observed, probably due
to a lack of correlation for drug resistant pairs (Figure 3b,
c). We speculate that this may be due to the different selec-
tion pressures and effective population sizes of the two
groups. The slope of the graph provides an estimate of mu-
tation rate, and for the sensitive isolates this is 0.32 SNPs
per genome per year but with a large degree of variation
around the mean reflected by an r2 value of 0.17. This vari-
ability could reflect a number of sources of error that have
to be taken into account. The first possible source of error
is the reliance on the assumption that the epidemiological
inference is correct and that there was true direct trans-
mission between the patient pairs. Secondly, there is an un-
known degree of error regarding how well the date of
transmission is represented by the date of isolation. Finally
the presence of SNPs in the primary case isolate of 26 pairs
(averaging 0.64 SNPs per pair) that were not found in the
secondary suggests that the sampled isolate is unlikely to
represent the transmitted population.
To control for the sources of error described above,
the mutation rate was also inferred from the entire data-
set, thus not requiring assumptions about the routes of
transmission. A date of isolation was available for 197 of
the isolates. The presence of a clock-like signal in this
dataset was investigated using Path-O-Gen [21], which
roots the maximum-likelihood tree at the position that is
most compatible with the assumption of the presence of a
molecular clock. Lineage specific phenotypes have been
frequently proposed [33,34], and due to the possibility that
the different lineages may have different mutation rates
we carried out this analysis per lineage. An absence of cor-
relation between the accumulation of SNPs and time was
observed for all the lineages (Figure 4). In order to control
for any time dependent variations in substitution rate and
cluster specific phenotypes, we also carried out this ana-
lysis on five of the largest clusters which are more likely to
represent the raw accumulation of SNPs in the absence of
selection (Figure 5a). The linear regression slope ranged
from 0.08 to 0.43 SNPs per genome per year, with this
variation probably reflecting the small number of isolates
and SNPs observed. When the cluster data was combined,
a mean rate could be estimated at 0.27 SNPs per genome
per year (95% CI 0.13, 0.41) (Figure 5b). Additionally,
when we plotted the age of the clusters against the num-
ber of SNPs accumulated, controlling for the number of
isolates, we also calculated a similar rate of 0.34 SNPs per
genome per year (Additional file 6).
In summary, three methods agreed on an average rate
of ~0.3 SNPs per genome per year which is remarkably
similar to that estimated by Ford et al. [10] using the tu-
berculosis macaque infection model. However, the cor-
relation co-efficient was consistently poor (maximum r2
value of 0.6 in one case) and the level of variation
observed at the isolate level was high. This is likely due
to the very low rate and stochastic nature of SNP accu-
mulation, and indicates that this estimate needs to be
used with caution.
Using the structure of the phylogeny to exclude
transmission
Instead of looking at possible transmission events in iso-
lation, deep sampling of a phylogenetic cluster can pro-
vide a context, which can be used to make more confident
inferences. The structure of a phylogeny can be used to
assess whether a direct transmission event is likely to
have occurred. Isolates that represent a recent transmis-
sion event are expected to be adjacent on the tree and
share a most recent common ancestor, as shown in
Figure 6d. If other isolates occupy the common nodes
between the linked isolates in question, then this is evi-
dence against direct transmission. This situation was
identified for two of the pairs in the study (Figure 6a
and 6b) which differed by 5 and 8 SNPs respectively.
However, it is possible that the source case could have
been carrying an infection with a “cloud” of diversity as
observed previously [35]. In such a scenario, the entire
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cluster may in fact represent within patient diversity
and each patient isolate is effectively a sample of this.
As liquid cultures (i.e. not colony purified) were used in
this study we were able to look for evidence of this by
inspecting whether heterozygosity was identifiable in
the variable positions between the pairs. We found no
such evidence, and in the absence of multiple samples
from each patient, this strongly suggests that these pairs
do not represent direct transmission events.
One pair from the East Asian linage had a particularly
large SNP difference of 149 (Figure 6c). The suspected
source case patient lived in the same street as the
suspected secondary case patient. It is however unclear
if they were in direct contact with each other. Both
isolates shared an IS6110 RLFP pattern but their 24-
locus VNTR pattern differed in 6 loci. With no detect-
able evidence of recombination or SNPs in possible
hypermutator genes, we examined the sequencing data
more closely and we were able to detect two independ-
ent deletions in the strains. The large deletion of part of
the pks1 gene found in the source isolate was found in
another East Asian strain, Beijing 30, in a previous study
[36]. This suggests that these non-epidemiologically linked
isolates share a more recent common ancestor than the an-
cestor of epidemiologically linked pair. This evidence along
with the large SNP difference means we can be confident
in excluding the possibility of recent direct transmission.
In the absence of whole genome sequencing, the clear
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Figure 3 Poor correlation between time and number of SNPs accumulated in the secondary case isolate for drug resistant and
sensitive isolates. Three pairs were excluded (see main text). SNPs conferring drug resistance were also removed. Resistant isolates are classed as
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genetic separation of these isolates would have been un-
detected.
Identifying novel transmission events
In low incidence countries, isolates of the same RFLP
type isolated from different patients may be indicative
of patient-patient transmission. In this dataset, 572 pairs
of isolates had identical RFLP types, which had SNP
distances ranging from 0–149, with a median of two
SNPs. Figure 7b, further confirms that the linked pair with
a SNP distance of 149 is a clear outlier showing that it is
distinct from the rest of the same-RFLP and epidemi-
ologically linked pairs. 95% of same-RFLP pairs have SNP
distances under 11, indicating that in general RFLP type is
a good indicator of phylogenetic relatedness. However,
whole genome sequencing provides a much higher reso-
lution. For example in Figure 6d, all of the isolates in this
cluster would be indistinguishable via RFLP, but at the
whole genome level individual transmission events can be
inferred. Figure 7b demonstrates that many pairs of
isolates of the same RFLP type, with currently no known
epidemiological link, have SNP distances which overlap
with the range observed between the 94 linked pairs.
Strikingly 82 pairs of these non-linked isolates, of the
sample RFLP type, had a SNP difference of zero. This
suggests that amongst these pairs there may be previously
un-detected transmission events. The range of date in-
tervals between these pairs ranged from zero days to al-
most 5 years, which further demonstrates the low and
variable mutation rate. In the absence of epidemiological
evidence, and the low and variable mutation rate observed,
we cannot confidently assess whether direct transmission
has occurred in these cases, however this information
would provide valuable evidence in a clinical setting, in-
forming further investigation and contact tracing.
Discussion
In summary, the low mutation rate of M. tuberculosis
means that even at the highest resolution provided by
whole genome sequencing it is still difficult to confidently
affirm the inferences of transmission made by traditional
epidemiological techniques. This means it is very difficult
to determine transmission inclusively. However, whole
genome sequencing does in some cases allow us to ex-
clude direct transmission, by using the phylogenetic con-
text provided by other strains. Not only does whole
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genome sequencing provide the inter-cluster differenti-
ation provided by current typing methods, but it also
achieves intra-cluster resolution which can be used to in-
form epidemiological investigation.
At the cluster level we were able to estimate an average
mutation rate of 0.3 SNPs per genome per year, which is
remarkably close to estimates made by Ford et al. [10].
This confirms the extremely low rate of accumulation of
Figure 5 Date of collection vs. root to tip SNP distance of the 5 largest clusters. A. Clusters were rooted using their topology in the entire
maximum likelihood tree. Linear regression was fitted using Path-O-Gen [21]. B. Data combined from A. Time represents days since first isolation
in the cluster. Shaded area indicates 95% confidence interval.
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variation that characterizes M. tuberculosis, which is ap-
proximately 3 times and 44 times slower than that ob-
served in Escherichia coli and Staphylococcus aureus,
respectively [37]. It is possible that lack of coverage and
mapping to repetitive regions and members of PE and
PPE gene families may have resulted in a lower estimated
mutation rate. However, it is worth noting that only 5% of
the genome on average was unrepresented in this analysis
so any effects on the estimated mutation rate are likely to
be negligible.
We were unable to detect a clock-like signal at a larger
phylogenetic scale (at the lineage level), probably reflecting
the different processes of fixation and substitution having
variable influences on different parts of the evolutionary
history. However, at the intra-cluster level and between
the epidemiologically linked pairs, we observed a large
level of variation around the mean, which is in contrast to
observations of some other bacteria [38,39]. There are a
variety of factors that may have contributed to this vari-
ability. Latency is common in tuberculosis infection and
could result in considerable discrepancies in the apparent
rate of mutation over time. However, Ford et al. recently
showed that the mutation rate during latency in macaques
was similar to that during active infection [10]. Within
host selection for factors such as drug resistance may also
result in variation in the accumulation of SNPs over time,
as observed for a single patient [9]. However, we propose
that the most important factor is probably the low muta-
tion rate itself, meaning over short time scales only a weak
signal of a molecular clock can be detected.
This variability means that although a molecular clock
may be detectable over longer time frames, it is only an
aggregate measure and should be used with extreme
caution when applying it to infer local transmission or
date recent evolutionary events. Furthermore, while mu-
tation rate can be used to strengthen or exclude epi-
demiological links, it cannot be used alone to infer
direct transmission, particularly due its slow rate. We
found no evidence of hyper-mutation in our dataset, and
this has not been reported in clinical M. tuberculosis
isolates to our knowledge. However it is possible that
treatment may impose selection pressures on isolates
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that could affect the observed rate of fixation, and this
should be considered.
In a recent investigation of tuberculosis transmission
chains in the UK [11], an estimate of 0.5 SNPs per genome
per year was derived using whole genome sequences from
both within-patient and within-household longitudinal
sampling. This estimate was based on the number of SNPs
accumulated between the first and last sequenced isolate
from each patient or transmission chain. Interestingly, the
estimate for within-patient mutation rate was identical to
our estimate of 0.3 SNPs per genome per year. The higher
between-patient rate they estimated may reflect the mul-
tiple sources of error when using the inferred epidemio-
logical links to derive mutation rates, which we observed
in our dataset. They used this estimate to set a cut-off of
≤5 SNPs for cases less than three years apart. Our more
in-depth analysis of the molecular clock reveals a high
level of variation which suggests that using a simple cut-
off may not be entirely accurate for confirming transmis-
sion, but that the phylogenetic context provided by deep
sampling of clusters may be more informative.
Conclusions
This dataset reveals that over transmission time scales,
the molecular clock of M. tuberculosis is both slow and
variable, indicating that genetic distance alone cannot be
used to confidently infer transmission. However we
propose future transmission studies of M. tuberculosis
will benefit from whole genome sequencing through the
increased resolution it provides. In addition we demon-
strate that deep sampling of a phylogenetic cluster will
provide the context to allow exclusion of possible trans-
mission events. The establishment of whole-genome
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databases will further enhance the possibility to compare
samples to exclude or propose transmission.
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